Detection of neonatal sepsis with non-invasive transcutaneous blood gas monitoring
Recruiting
- Conditions
- prematuriteitblood poisoningSepsis1000590810019815
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 64
Inclusion Criteria
A gestational age of 24 weeks up to and including 31 weeks at the time of
inclusion.
A pulse oximeter.
Written informed consent
Exclusion Criteria
A gestational age of 32 weeks or more at the time of inclusion.
Skin condition contraindicating transcutaneous measurements.
Absence of written informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link transcutaneous blood gas monitoring to neonatal sepsis detection in preterm infants?
How does non-invasive transcutaneous blood gas monitoring compare to traditional blood culture methods in detecting neonatal sepsis?
Which biomarkers correlate with transcutaneous blood gas parameters in early-onset neonatal sepsis cases?
What are the potential adverse events associated with transcutaneous blood gas monitoring in neonatal intensive care units?
Are there combination approaches using transcutaneous blood gas monitoring with other non-invasive technologies for improved neonatal sepsis outcomes?